Resumen
Adaptive optics scanning light ophthalmoscopy (AOSLO) allows noninvasive assessment of the cone photoreceptor mosaic. Confocal AOSLO imaging of patients with achromatopsia (ACHM) reveals an altered reflectivity of the remaining cone structure, making identification of the cells more challenging than in normal retinas. Recently, a “split-detector” AOSLO imaging method was shown to enable direct visualization of cone inner segments in patients with ACHM. Several studies have demonstrated gene replacement therapy effective in restoring cone function in animal models of ACHM and human trials have on the horizon, making the ability to reliably assess cone structure increasingly important. Here we sought to examine whether absolute estimates of cone density obtained from split-detector and confocal AOSLO images differed from one another and whether the inter- and intra-observer reliability is significantly different between these modes. These findings provide an important foundation for evaluating the role of these images as tools to assess the efficacy of future gene therapy trials.
| Idioma original | English |
|---|---|
| Título de la publicación alojada | Advances in Experimental Medicine and Biology |
| Páginas | 277-283 |
| Número de páginas | 7 |
| DOI | |
| Estado | Published - oct 1 2016 |
Serie de la publicación
| Nombre | Advances in Experimental Medicine and Biology |
|---|---|
| Volumen | 854 |
| ISSN (versión impresa) | 0065-2598 |
| ISSN (versión digital) | 2214-8019 |
Nota bibliográfica
Publisher Copyright:© Springer International Publishing Switzerland 2016.
Financiación
The work was supported by grants from the The Wellcome Trust [099173/Z/12/Z], National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and UCL Institute of Ophthalmology, NIH grants R01EY017607, R24EY022023, P30EY001931, C06RR016511, & UL1TR000055, Fight For Sight (UK), Moorfields Eye Hospital Special Trustees, the Foundation Fighting Blindness (USA), RP Fighting Blindness, an unrestricted departmental grant from Research to Prevent Blindness (RPB). Dr. Michaelides is supported by an FFB Career Development Award.
| Financiadores | Número del financiador |
|---|---|
| Moorfields Eye Hospital Special Trustees | |
| National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust | |
| RP Fighting Blindness | |
| National Institutes of Health (NIH) | UL1TR000055, R24EY022023, P30EY001931, C06RR016511 |
| National Eye Institute (NEI) | R01EY017607 |
| Foundation Fighting Blindness | |
| Research to Prevent Blindness | |
| Wellcome Trust | 099173/Z/12/Z |
| Fight for Sight Inc | |
| UCL Institute of Ophthalmology, University College London |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
Huella
Profundice en los temas de investigación de 'Reliability and repeatability of cone density measurements in patients with congenital achromatopsia'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver